Atricure Inc. buy UBS Group AG
Start price
18.02.26
/
50%
€27.40
Target price
18.02.27
€46.43
Performance (%)
-7.30%
Price
02.04.26
?
Summary
This prediction is currently active. With a performance of -7.30%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 18.02.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -3.200% | -3.200% |
| iShares Core DAX® | 1,60 % | -7,45 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % |
| iShares S&P 500 | -0,39 % | -2,34 % |
Comments by UBS_Group_AG for this prediction
In the thread Atricure Inc. diskutieren
AtriCure (NASDAQ:ATRC) was given a new $55.00 price target on by analysts at UBS Group AG. They now have a "buy" rating on the stock.
Ratings data for ATRC provided by MarketBeat